BMP6 and ocular melanoma: Matrix marker type I collagen was significantly up-regulated in BMP6-treated MMs at 4 weeks compared to OM controls (n = 6, p < 0.01), and both treatments resulted in increased expression relative to d0 levels (Fig. 8D).